Table 1 Correlation of Aurora-B protein expression levels in OS tissues with clinical pathologic parameters
From: Aurora-B knockdown inhibits osteosarcoma metastasis by inducing autophagy via the mTOR/ULK1 pathway
Variables | All cases | Aurora-B expression | P value | |
|---|---|---|---|---|
Low | High | |||
Gender | ||||
 Male | 40 | 19 (47.5%) | 21 (52.5%) | 0.328 |
 Female | 29 | 18 (62.1%) | 11 (37.9%) |  |
Age | ||||
  ≤ 20 | 33 | 19 (57.6%) | 14 (42.4%) | 0.631 |
  > 20 | 36 | 18 (50%) | 18 (50%) |  |
Location | ||||
 Femur/Tibia | 53 | 27 (50.9%) | 26 (49.1%) | 0.569 |
 Elsewhere | 16 | 10 (62.5%) | 6 (37.5%) |  |
Tumor size (cm) | ||||
  ≤ 5 | 23 | 16 (69.6%) | 7 (30.4%) | 0.076 |
  > 5 | 46 | 21 (45.7%) | 25 (54.3%) |  |
Enneking staging | ||||
 I + IIA | 40 | 26 (65%) | 14 (35%) | 0.031* |
 IIB + III | 29 | 11 (37.9%) | 18 (62.1%) |  |
LC3B expression | ||||
 Low | 34 | 13 (38.2%) | 21 (61.8%) | 0.016* |
 High | 35 | 24 (68.6%) | 11 (31.4%) |  |